DA32 Life Science Tech Acquisition (DALS) Stock Price, News & Analysis

Company Overview

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Key Stats

• Today's Range: $10.30 to $10.32
• 50-Day Range: $10.25 to $10.32
• 52-Week Range: $9.68 to $11.22
• Volume: 2,248 shs
• Average Volume: 88,802 shs
• Market Capitalization: $264.71 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DALS Stock Analysis - Frequently Asked Questions

When did DA32 Life Science Tech Acquisition IPO?

DA32 Life Science Tech Acquisition (DALS) raised $200 million in an initial public offering (IPO) on Wednesday, July 28th 2021. The company issued 20,000,000 shares at $10.00 per share.

What other stocks do shareholders of DA32 Life Science Tech Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that DA32 Life Science Tech Acquisition investors own include Bridge Investment Group (BRDG), Blend Labs (BLND), Blue Foundry Bancorp (BLFY), Couchbase (BASE), ARYA Sciences Acquisition Corp V (ARYE), Argo Blockchain (ARBK) and a.k.a. Brands (AKA).

Company Calendar

• Today: 5/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: Holding & other investment offices
• Sub-Industry: N/A
• Current Symbol: NASDAQ:DALS
• CIK: 1863294
• Web: da32lifescience.tech
• Phone: 212551600
• Fax: N/A
• Employees: 2,021
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $600 thousand
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -37.55%
• Return on Assets: 0.85%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.36
• Quick Ratio: 0.36

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.02 per share
• Price / Cash Flow: 441.92
• Book Value: ($0.18) per share
• Price / Book: -57.33

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: $264.71 million
• Optionable: Not Optionable
• Beta: N/A